A comprehensive study in Finland will investigate whether the shingles vaccine reduces the incidence of dementia in individuals aged 76 and older.
A large-scale research initiative named FinDementia is set to commence in Finland, focusing on the potential link between the shingles vaccine and reduced dementia risk among individuals aged 76 and older. The study will encompass over 33,000 participants from various regions across Finland. Observational study evidence has recently suggested that the shingles vaccine might correlate with a lower risk of dementia and reduced cardiovascular events. Despite promising consistent results, establishing a causal relationship necessitates extensive randomized trials.
